1 min read
Add as a preferred source on Google

Elanco Animal Health Approves Stock Buyback Authorization of Up to $600 Million

The Nov. 19 authorization reflects the company’s operating momentum, free cash flow generation and strengthened balance sheet.

An unmarked share certificate rests beside a circular cutout in ivory paper / TokenPost.ai
An unmarked share certificate rests beside a circular cutout in ivory paper / TokenPost.ai

Elanco Animal Health’s board authorized the company to repurchase up to $600 million of its common stock, a capital-return plan that reflects its operating momentum and financial position.

The authorization was announced Nov. 19. Elanco said it reflects accelerating operating momentum, robust free cash flow generation, a strengthened balance sheet and a clear path to net leverage.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…